SCHEMBL17040868

SCHEMBL17040868

c1ccc(-c2cccc(N(c3ccccc3)c3ccccc3-c3ccccc3-c3ccc4c5ccccc5n(-c5ccccc5)c4c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
TSPO P30536 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
HDAC4 P56524 1/20 0.31
KMT2A Q03164 2/20 0.31
IL1R1 P14778 1/20 0.31
METAP2 P50579 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17040891 0.99 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17056484 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17040814 0.94 KDM4E (0.36) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL18561158 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17056500 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL16947125 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17040873 0.93 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17040872 0.93 ATM (0.36) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17040890 0.93 L3MBTL1 (0.46) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL17041527 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700285-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-06-30 US disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 US disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 US disclosed
WO-2015126090-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2015-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, PIEZO1 L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885
US-10700285-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof GPX1, OR51E2, PIEZO1 L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.